Finance and funding: latest news

Finance and funding features

Finance and funding news from aidsmap

More news

Finance and funding news selected from other sources

  • In first, healthcare provider to subsidize HIV medication

    The decision by Meuhedet to subsidize a generic version of the drug Truvada is set to drive a dramatic drop in prices for HIV medication. Under the new policy, Meuhedet patients were expected to pay NIS 300-500 ($83-$138) for the medication instead of the current cost of some NIS 2,100 ($580).

    08 August 2017 | The Times of Israel
  • Government could end HIV transmission in Australia with just $32m year

    A new plan developed by the Australian Federation of AIDS Organisations says the investment would not only prevent thousands of people contracting the virus but would also eventually deliver $2 billion of savings to the federal government's budget.

    07 August 2017 | The Sydney Morning Herald
  • A massive second global wave of AIDS is coming — perhaps within the next 10 years

    Three problems are driving the global fight against HIV into a new danger zone. First, new infections increasingly involve forms of the virus that are already resistant to the primary drugs used to treat and prevent HIV infection. Second, the world is fast approaching the limits of manufacturing capacity for anti-HIV first-line drugs, and the ceiling is far lower for second- and third-line treatments. And third, there aren’t sufficient financial resources applied to the AIDS problem now, and signals from major donors — especially the U.S. government — offer a grim future of diminished resources and greater demands on very poor countries to finance their own HIV fights without outside help.

    31 July 2017 | Business Insider
  • Leaders make case for continued global HIV funding, herald critical role of science in the fight against HIV

    HIV experts joined forces in an official press conference at the 9th IAS Conference on HIV Science (IAS 2017) today to issue a strong call for a renewed global commitment to funding for HIV research and programmes, highlighting the return on investment for governments, communities and the private sector.

    24 July 2017 | International AIDS Society
  • Kaiser/UNAIDS Study Finds Donor Government Funding for HIV Declined by 7% in 2016, Falling to Lowest Level Since 2010

    Donor government funding to support HIV efforts in low- and middle-income countries decreased by US$511 million from US$7.5 billion in 2015 to US$7 billion in 2016, finds a new report from the Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS). This marks the second successive year of declines, and is the lowest level since 2010.

    21 July 2017 | Kaiser Family Foundation
  • Declining Funding and Shrinking Donor Base Imperils Continued Success of HIV Prevention

    A new report released today ahead of the 9th IAS Conference on HIV Science documents 2016 funding and highlights a continuing trend of flat or declining funding and its potential impact on further innovation in HIV prevention research and development (R&D).

    21 July 2017 | AVAC
  • AIDS deaths are almost half of what they were in 2005 — but experts worry Trump could reverse that

    “If the president’s budget were enacted, we would see the progress that has been gained over the last decade reversed very quickly, and all of the hard-fought gains reversed almost quicker than we achieved them,” said Mitchell Warren, executive director of HIV-prevention advocacy group AVAC.

    21 July 2017 | Mic
  • Threatened Funding Cuts in Limelight at AIDS 2017

    Researchers, clinicians, and advocates converging in Paris for the International AIDS Conference 2017 will not only be talking about new HIV treatment and prevention and how to roll out innovative medications in a comprehensive, integrated way, they will also be making a case to funders.

    19 July 2017 | Medscape (free registration required)
  • Gates is Still Gunning for HIV. Here's the Latest

    One area of focus in the foundation’s five-point strategy is improving diagnostic testing. This area may not sound as critical as ensuring access to antiretroviral medication. In fact, though, improving diagnosis can go a long way toward stopping the spread of HIV.

    19 July 2017 | Inside Philanthropy
  • Chickens coming home to roost: local government public health budgets for 2017/18

    Although some local authorities have been innovative in contracting and in seeking efficiencies in their public health budgets, there is little doubt that we are now entering the realms of real reductions in public health services. This is a direct result of the reduced priority that central government gives to public health.

    13 July 2017 | The King's Fund
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.